Pacquiao camp blames denial of 'anti-inflammatory injection' for defeat against Mayweather

Image
ANI Sydney
Last Updated : May 04 2015 | 1:48 PM IST

After losing a closely fought battle against unbeaten US boxing champion Floyd Mayweather Jr., Manny Pacquiao's camp has attributed the Filipino boxer's defeat to the denial to receive an anti-inflammatory injection for his right shoulder injury before the bout in Las Vegas on Saturday night.

Mayweather extended his unbeaten record to 48-0 with a unanimous-decision victory over Pacquiao in the 'fight of the century' bout at MGM Grand.

Pacquiao's promoter Bob Arum said Nevada Athletic Commission's refusal to allow an anti-inflammatory shot for the boxer before the mega-bout affected the outcome the fight, News.com.au reported.

Meanwhile, Francisco Aguilar, chairman of the NAC, said that the Pacquiao team did not bring to their notice about his injury until Saturday night, and therefore the requests for permission to take the shot had to be ruled out.

Defending his stance, Pacquiao said that it was a part of the game, claiming that he didn't want to make alibis or complain but insisted that it was hard to fight one-handed.

Arum also said that they felt that the work that was done on the shoulder during training would give him the opportunity to use the right hand without the shot, adding that they were disappointed when the injury kicked up again in the third round.

Despite Pacquiao's limitations, Arum insisted that he fought a courageous fight under all the circumstances, adding that he was very proud of what he had accomplished then.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 04 2015 | 1:36 PM IST

Next Story